LGALS3 and prostate neoplasm: According to the results of the present work (Figure 2), in silico analysis revealed that the expression of Gal-3 was found to be decreased in tumours (p < 1 × 10−12) and prostate tumours with a GS of 6 (p = 1.63 × 10−12), 7 (p < 1 × 10−12), and 8 (p = 2.11 × 10−12), compared with normal prostate (Figure 6A,B and Figure 7A).